September 23, 2016 BORDEAUX, France & BOSTON–(BUSINESS WIRE)– IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible) (IMPL.PA) (OTCQX:IMPZY), a medical technology company specializing in vertebral and knee-surgery implants, today announces its financial results for the 1st half of the year to June 30, 2016, as approved by the Board at its meeting of September 20, 2016. In € […]